Covestor’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Buy
60
+42
+233% +$486 ﹤0.01% 2053
2026
Q2
$0 Buy
18
+13
+260% +$186 ﹤0.01% 2515
2026
Q1
$0 Hold
5
– – ﹤0.01% 2311
2025
Q4
$0 Sell
5
-3
-38% -$45 ﹤0.01% 2309
2025
Q3
$0 Buy
8
+3
+60% +$35 ﹤0.01% 2329
2025
Q2
$0 Sell
5
-1
-17% -$12 ﹤0.01% 2260
2025
Q1
$0 Buy
6
+1
+20% +$17 ﹤0.01% 2272
2024
Q4
$0 Hold
5
– – ﹤0.01% 2280
2024
Q3
$0 Hold
5
– – ﹤0.01% 2270
2024
Q2
$0 Buy
+5
New +$88 ﹤0.01% 2281

Other funds holding CLB

Covestor's CLB Position: Q3 2026 in Review

Covestor increased its Core Laboratories (CLB) stake by 233% in Q3 2026, buying an estimated $486 and bringing the position to 60 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Covestor first reported a position in CLB in Q2 2024 and has held it in 10 quarters since. 131 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Covestor held 60 shares of Core Laboratories worth $1K as of Q3 2026.
  • Covestor bought 42 Core Laboratories shares in Q3 2026, an estimated $486.
  • Core Laboratories made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2053 holding.
  • Covestor first reported a position in Core Laboratories in Q2 2024 and has held it in 10 quarters since.
  • 131 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.